We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

Find a share

Search for UK shares

Search

Market movers

United Kingdom
movers are constituents of the FTSE 350.
% GainersCompany
content
IC ViewLastChange
Serco Group PLC
SRP:LSE
125.80
GBX
+7.80
+6.61%
AVEVA Group PLC
AVV:LSE
1,882
GBX
+74.00
+4.09%
AA PLC
AA.:LSE
383.90
GBX
+13.20
+3.56%
Ocado Group PLC
OCDO:LSE
464.00
GBX
+18.10
+4.06%
Betfair Group PLC
BET:LSE
2,492
GBX
+86.00
+3.57%
N Brown Group PLC
BWNG:LSE
354.60
GBX
+12.40
+3.62%
Royal Bank of Scotland Group PLC
RBS:LSE
363.10
GBX
+11.60
+3.30%
Merlin Entertainments PLC
MERL:LSE
441.00
GBX
+13.90
+3.25%
Hiscox Ltd
HSX:LSE
865.00
GBX
+26.00
+3.10%
Close Brothers Group PLC
CBG:LSE
1,574
GBX
+46.00
+3.01%
As of Jul 01 2015 16:26 BST.

Companies news

Who bought who
Deal status
Deal value
Date
Willis Group Holdings PLCacquiredTowers Watson & CoAnnounced8.37bn30 Jun 2015
Eckoh PLCacquiredNetcall PLCAnnounced138.07m25 Jun 2015
Emerson Electric CoacquiredSpectronix LtdAnnounced99.00m29 Jun 2015
Tourmaline Oil CorpacquiredMapan Energy LtdAnnounced84.67m29 Jun 2015
First Merchants CorpacquiredAmeriana BancorpAnnounced69.59m29 Jun 2015
1-5 of 12 results

Companies news

Financial Times articles may require a separate login and/or subscription to FT.com

Stagecoach starts park-and-ride scheme
Domus Italia shelves planned float
Edgy East End chic pitches into golfing palace
Danish court rules against Ryanair
John Lewis ends free click and collect

Featured company

Epistem Holdings PLCEHP:LSE

Epistem Holdings Plc (Epistem) is a United Kingdom-based biotechnology company focusing on epithelial stem cells in the areas of oncology, gastrointestinal disease, dermatology and ageing

© Thomson Reuters Click for restrictions.

All markets data located on Investors Chronicle is subject to the Investors Chronicle Terms & Conditions.

All content on Investors Chronicle is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Investors Chronicle and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Conditions.

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply